210 related articles for article (PubMed ID: 23446994)
1. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
Thromb Haemost; 2013 May; 109(5):854-68. PubMed ID: 23446994
[TBL] [Abstract][Full Text] [Related]
2. ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies.
Lorenzo C; Delgado P; Busse CE; Sanz-Bravo A; Martos-Folgado I; Bonzon-Kulichenko E; Ferrarini A; Gonzalez-Valdes IB; Mur SM; Roldán-Montero R; Martinez-Lopez D; Martin-Ventura JL; Vázquez J; Wardemann H; Ramiro AR
Nature; 2021 Jan; 589(7841):287-292. PubMed ID: 33268892
[TBL] [Abstract][Full Text] [Related]
3. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.
Satta N; Vuilleumier N
Curr Drug Targets; 2015; 16(4):342-60. PubMed ID: 25429713
[TBL] [Abstract][Full Text] [Related]
4. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.
Veres A; Füst G; Smieja M; McQueen M; Horváth A; Yi Q; Bíró A; Pogue J; Romics L; Karádi I; Singh M; Gnarpe J; Prohászka Z; Yusuf S;
Circulation; 2002 Nov; 106(22):2775-80. PubMed ID: 12451002
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
6. A role for autoantibodies in atherogenesis.
Iseme RA; McEvoy M; Kelly B; Agnew L; Walker FR; Handley T; Oldmeadow C; Attia J; Boyle M
Cardiovasc Res; 2017 Aug; 113(10):1102-1112. PubMed ID: 28899001
[TBL] [Abstract][Full Text] [Related]
7. The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.
Meier LA; Binstadt BA
Front Immunol; 2018; 9():911. PubMed ID: 29755478
[TBL] [Abstract][Full Text] [Related]
8. Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.
Teixeira PC; Ducret A; Ferber P; Gaertner H; Hartley O; Pagano S; Butterfield M; Langen H; Vuilleumier N; Cutler P
J Biol Chem; 2014 Oct; 289(41):28249-59. PubMed ID: 25170076
[TBL] [Abstract][Full Text] [Related]
9. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta N; Frias MA; Vuilleumier N; Pagano S
Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
[TBL] [Abstract][Full Text] [Related]
10. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.
Chistiakov DA; Orekhov AN; Bobryshev YV
Lab Invest; 2016 Jul; 96(7):708-18. PubMed ID: 27183204
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis and autoimmunity: a growing relationship.
Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases.
Vaarala O
J Intern Med; 2000 Mar; 247(3):381-4. PubMed ID: 10762455
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.
Teixeira PC; Cutler P; Vuilleumier N
Clin Dev Immunol; 2012; 2012():868251. PubMed ID: 23227091
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.
Shi GP
Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):485-94. PubMed ID: 20188603
[TBL] [Abstract][Full Text] [Related]
15. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Toubi E; Shoenfeld Y
Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
[TBL] [Abstract][Full Text] [Related]
16. Anti-endothelial cell antibodies are increased in patients with previous myocardial infarction.
Elsheikh E; Sylvén C; Henareh L
Scand Cardiovasc J; 2010 Oct; 44(5):255-9. PubMed ID: 20528242
[TBL] [Abstract][Full Text] [Related]
17. Definition of human autoimmunity--autoantibodies versus autoimmune disease.
Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME
Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079
[TBL] [Abstract][Full Text] [Related]
18. Updating concepts on atherosclerotic inflammation: From pathophysiology to treatment.
Ministrini S; Carbone F; Montecucco F
Eur J Clin Invest; 2021 May; 51(5):e13467. PubMed ID: 33259635
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of antibodies against heat shock proteins in stroke patients.
Banecka-Majkutewicz Z; Grabowski M; Kadziński L; Papkov A; Węgrzyn A; Banecki B
Acta Biochim Pol; 2014; 61(2):379-83. PubMed ID: 24904931
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
Nilsson J; Wigren M; Shah PK
Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
